181 related articles for article (PubMed ID: 22157222)
1. Pathologic complete response after FOLFOX7 in a locally advanced rectal cancer.
Li J; Rose MG; Perkal MF; Chao HH
J Clin Gastroenterol; 2012 Jan; 46(1):87-8. PubMed ID: 22157222
[No Abstract] [Full Text] [Related]
2. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
[TBL] [Abstract][Full Text] [Related]
3. [Complete clinical and pathological response to mFOLFOX6 neoadjuvant chemotherapy in a case of advanced rectal cancer].
Mori K; Kikunaga H; Morisue A; Fujita K; Ishikawa K; Sakuragawa T; Kumai K; Miura H; Mikami S
Gan To Kagaku Ryoho; 2012 Apr; 39(4):679-82. PubMed ID: 22504702
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
5. [A case of locally advanced rectal cancer responding to FOLFOX].
Kume S; Kubota T; Takahashi M; Hashimoto D; Hirata T; Torigoe Y; Ikeda O
Gan To Kagaku Ryoho; 2009 Apr; 36(4):659-61. PubMed ID: 19381043
[TBL] [Abstract][Full Text] [Related]
6. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Geisler D; Dietz DW; Lavery IC; Fazio VW; Kalady MF
Ann Surg Oncol; 2011 Jun; 18(6):1590-8. PubMed ID: 21207164
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome.
Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A; Scott N; Marone P; Aloi L; Sandomenico C; Lastoria S; Iaffaioli VR; Scala D; Iodice G; Budillon A; Comella P
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):670-6. PubMed ID: 20472346
[TBL] [Abstract][Full Text] [Related]
8. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG
Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185
[TBL] [Abstract][Full Text] [Related]
9. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
10. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization.
Habr-Gama A; Perez RO; Wynn G; Marks J; Kessler H; Gama-Rodrigues J
Dis Colon Rectum; 2010 Dec; 53(12):1692-8. PubMed ID: 21178866
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
12. [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
Sueda T; Noura S; Ohue M; Shingai T; Gotoh K; Motoori M; Takahashi H; Kishi K; Marubashi S; Fujiwara Y; Ohigashi H; Yano M; Tomita Y; Ishikawa O
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1965-7. PubMed ID: 24393981
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?
Hong TS; Ryan DP
J Clin Oncol; 2015 Jun; 33(17):1878-80. PubMed ID: 25940719
[No Abstract] [Full Text] [Related]
14. [A prospective study of FOLFOX7 scheme as neoadjuvant chemotherapy for stage III gastric adenocarcinoma].
Liu YH
Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(17):1305-8. PubMed ID: 20092724
[TBL] [Abstract][Full Text] [Related]
15. [A case of unresectable rectal cancer with severe pelvic infiltration responding to FOLFOX].
Yamazoe S; Yamaguchi K; Terasawa H; Ojima T; Tsujimura H; Shimomura T
Gan To Kagaku Ryoho; 2011 Jan; 38(1):125-8. PubMed ID: 21368473
[TBL] [Abstract][Full Text] [Related]
16. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?
Chen CC; Lee RC; Lin JK; Wang LW; Yang SH
Dis Colon Rectum; 2005 Apr; 48(4):722-8. PubMed ID: 15747073
[TBL] [Abstract][Full Text] [Related]
17. [A case of adenocarcinoma occurring at colostomy site 7 years after abdominoperineal resection for rectal cancer resected after preoperative mFOLFOX6 chemotherapy].
Hata T; Tsuruta Y; Takamori S; Shishikura Y
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1431-3. PubMed ID: 22996785
[TBL] [Abstract][Full Text] [Related]
18. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
Schrag D; Weiser M; Schattner M; Shia J; Akhurst T
J Clin Oncol; 2005 Mar; 23(9):1799-802. PubMed ID: 15774773
[No Abstract] [Full Text] [Related]
19. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy of irinotecan, 5-fluorouracil and leucovorin in patients with advanced rectal cancer. Report of two cases.
Hasegawa H; Watanabe M; Baba H; Yoshinare K; Mukai M; Kubota T; Kitajima M
Hepatogastroenterology; 2002; 49(46):891-3. PubMed ID: 12143234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
